Webinar
11 May 2022

CPHI Webinar Series How is M&A Shifting the Pharma Manufacturing Landscape?

What will this webinar address? Innovative manufacturing technologies are creating fresh deal-making opportunities for Pharma Manufacturers and CDMOs across both small and large molecule sectors, which are in turn transforming the pharma manufacturing landscape. Partnerships and mergers are a key tool for adding value to pharmaceutical companies; helping to navigate technological limitations, address portfolio challenges and chase innovation. This webinar, delivered in partnership with PharmaVentures, will examine the trends and developments driving deal-making in the current market. When you attend this webinar, you will discover: The key acquisition drivers for Pharma Manufacturers and CDMOs (tech, therapy areas, patent losses, portfolio challenges) What does the future look like? Prior to the COVID-19 pandemic, M&A activity in pharmaceuticals was soaring with $414 billion worth of deals in 2019 . What will the short to mid-term impact be on deal-making? How is ‘reshoring’ transforming the pharma manufacturing map and impacting Governments?

Content provided by our supplier

PHARMAVENTURES LTD

  • GB
  • 2020
    On CPHI since
  • 25 - 49
    Employees
Company types
Consultancy

Other Content from PHARMAVENTURES LTD (1)